Assiut University: Leukemia, Myeloid trials

The registry lists 15 Leukemia, Myeloid studies with Assiut University as lead sponsor. 2 are open to participants now and 0 have results posted.

Early Phase 1 1No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Evaluation of CD47, "Do Not Eat Me" Signal Expression in Chronic Myeloid LeukemiaNot yet recruitingNCT06865443
• Frequency and Risk Factors of Acute Myeloid LeukemiaNot yet recruitingNCT05787951
• CD155 Expression in Acute Myeloid LeukemiaCompletedNCT06369662
• Clinical Characters and Outcome of Acute Myeloid Leukemia Patients on Correlation to CD200 and CD56 ExpressionStatus unknownNCT05512104
• FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid Leukemia.Status unknownNCT05383014
• TIGIT in Patients With Chronic Myeloid LeukemiaStatus unknownNCT04818619
• Outcomes of Acute Myeloid Leukemia PatientsStatus unknownNCT04392310
• Immunophenotyping and Xist Gene in AMLStatus unknownNCT04288739
• PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid LeukemiaStatus unknownNCT04215822
• Chronic Myloid Leukemic Patients Treated With Tyrosine Kinase InhibitorStatus unknownNCT03907670
• Comparison of Diagnostic Yield Among M-FISH, FISH Probe Panel and Conventional Cytogenetic Analysis in AMLCompletedNCT03719183
• Cd11b and Cd56 as Prognostic Markers in Acute Myeloid LeukemiaStatus unknownNCT03283228
• Effect of Pharmacogenetics on Imatinib Plasma Level and ResponseCompletedNCT03262974
• Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid LeukemiaStatus unknownNCT03228303Early Phase 1
• Myeloid Derived Suppressor Cells and Chronic Myeloid LeukemiaStatus unknownNCT03214718Not applicable